|
DUSP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.945700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.342500E-02 |
| Normal-vs-Stage2 |
9.853700E-02 |
| Normal-vs-Stage3 |
7.796100E-02 |
| Normal-vs-Stage4 |
2.631700E-02 |
| Stage1-vs-Stage2 |
4.328200E-01 |
| Stage1-vs-Stage3 |
5.402400E-01 |
| Stage1-vs-Stage4 |
1.021880E-02 |
| Stage2-vs-Stage3 |
8.166600E-01 |
| Stage2-vs-Stage4 |
8.740200E-02 |
| Stage3-vs-Stage4 |
3.384000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.994000E-02 |
| Normal-vs-AfricanAmerican |
4.510000E-02 |
| Normal-vs-Asian |
2.220200E-01 |
| Caucasian-vs-AfricanAmerican |
6.857600E-01 |
| Caucasian-vs-Asian |
2.665400E-01 |
| AfricanAmerican-vs-Asian |
3.928600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.382300E-02 |
| Normal-vs-Female |
3.949800E-02 |
| Male-vs-Female |
1.806020E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.187800E-02 |
| Normal-vs-Extreme_Weight |
5.308200E-02 |
| Normal-vs-Obese |
5.790000E-02 |
| Normal-vs-Extreme_Obese |
4.149600E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.269000E-01 |
| Normal_Weight-vs-Obese |
6.168200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.657200E-01 |
| Extreme_Weight-vs-Obese |
9.753200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.513200E-01 |
| Obese-vs-Extreme_Obese |
6.128600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.864100E-02 |
| Normal-vs-Age(41-60Yrs) |
5.464000E-02 |
| Normal-vs-Age(61-80Yrs) |
4.804200E-02 |
| Normal-vs-Age(81-100Yrs) |
4.578400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.610800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.310800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.935800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.539600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.798600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.825400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.494100E-02 |
| Normal-VS-Type2 PRCC |
8.676200E-02 |
| Normal-VS-KIRP CIMP |
1.901790E-01 |
| Normal-VS-Unclassified PRCC |
3.877500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.852400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.437600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.800000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.523400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.453010E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.755200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.014300E-02 |
| Normal-vs-N1 |
8.172300E-02 |
| Normal-vs-N2 |
2.943600E-02 |
| N0-vs-N1 |
6.803600E-01 |
| N0-vs-N2 |
8.424400E-02 |
| N1-vs-N2 |
1.248400E-01 |
|
|
